SM
SRPT icon

Sabby Management’s Sarepta Therapeutics SRPT Stock Holding History

Sabby Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-76
Closed -$1.07M – 146
2020
Q3 		$1.07M Buy
+76
New +$11.6K 0.16% 61
2019
Q1 		– Sell
-864
Closed -$9.43M – 123
2018
Q4 		$9.43M Sell
864
-44
-5% -$5.5K 2.07% 10
2018
Q3 		$14.7M Hold
908
– – 1.88% 14
2018
Q2 		$12M Buy
908
+20
+2% +$1.89K 1.85% 14
2018
Q1 		$6.58M Sell
888
-584
-40% -$38.9K 0.78% 22
2017
Q4 		$8.19M Buy
1,472
+954
+184% +$50.5K 0.75% 27
2017
Q3 		$2.35M Buy
518
+452
+685% +$18.1K 0.15% 52
2017
Q2 		$222K Buy
+66
New +$2.15K 0.01% 174
2017
Q1 		– Sell
-19,251
Closed -$52.8M – 310
2016
Q4 		$52.8M Sell
19,251
-7,497
-28% -$301K 3.07% 9
2016
Q3 		$164M Sell
26,748
-2,502
-9% -$75.6K 6.15% 5
2016
Q2 		$55.8M Buy
29,250
+20,426
+231% +$378K 2.91% 7
2016
Q1 		$17.2M Buy
8,824
+5,522
+167% +$96.5K 0.86% 21
2015
Q4 		$12.7M Buy
3,302
+1,466
+80% +$47.5K 0.7% 22
2015
Q3 		$5.89M Buy
1,836
+159
+9% +$5.39K 0.24% 68
2015
Q2 		$5.1M Buy
1,677
+698
+71% +$14.3K 0.19% 89
2015
Q1 		$1.3M Buy
+979
New +$13K 0.05% 172
2014
Q4 		– Sell
-423
Closed -$893 – 273
2014
Q3 		$893 Sell
423
-1,270
-75% -$28.7K 0.03% 157
2014
Q2 		$5.04M Sell
1,693
-2,367
-58% -$74.8K 0.22% 61
2014
Q1 		$9.76M Sell
4,060
-3,413
-46% -$87K 0.55% 44
2013
Q4 		$15.2M Sell
7,473
-5,555
-43% -$165K 0.97% 24
2013
Q3 		$61.5M Buy
13,028
+7,557
+138% +$291K 4% 4
2013
Q2 		$20.8M Buy
+5,471
New +$196K 1.39% 20

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sabby Management's SRPT Position: Q1 2017 in Review

Sabby Management sold out of Sarepta Therapeutics (SRPT) in Q1 2017, closing a stake of 2,014,787 shares — an estimated $62.4M sold.

Sabby Management first reported a position in SRPT in Q2 2013 and held it in 13 quarters. The position peaked at $55.3M in Q4 2016. 179 funds tracked by Wall St. Rank hold SRPT as of Q1 2017.

  • Sabby Management reported no remaining Sarepta Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Sabby Management sold 2,014,787 Sarepta Therapeutics shares in Q1 2017, an estimated $62.4M.
  • Sabby Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 13 quarters.
  • Sabby Management's Sarepta Therapeutics position peaked at $55.3M in Q4 2016.
  • 179 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.